Molecular Analysis of Uterine Receptivity
Molecular Analysis of Uterine Receptivity
批准号:
10217213
负责人:
JOHN P LYDON
金额:
$33.32万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-01 至 2024-07-31
关键词:
AddressAdvanced DevelopmentAllelesAssisted Reproductive TechnologyBiopsyCRISPR/Cas technologyCell CompartmentationCell physiologyCellsClinicalCre driverDeciduaDecidual CellDecidual Cell ReactionsDevelopmentDiagnosisDiagnosticEmbryoEmbryonic DevelopmentEndometrialEndometrial Stromal CellEndometriumEngineeringEpithelialEpithelial CellsEventFemale infertilityFertilityFutureGene Expression ProfileGenetic TranscriptionGenomicsGoalsGrowthHigh Risk WomanHumanImpairmentIn VitroIndividualInfertilityKnowledgeMediatingMediator of activation proteinMenstrual cycleMolecularMolecular AnalysisMusNational Institute of Child Health and Human DevelopmentOocytesOutcome StudyPhasePregnancyPregnancy lossProcessProgesteroneProgesterone ReceptorsRegulationRegulatory ElementReportingReproductive HealthRoleSignal TransductionSpontaneous abortionStromal CellsTestingTherapeuticTranscriptional RegulationUterusWomanZNF145 genebasecell typeclinically relevantclinically significantearly pregnancyfailure Implantationgene repressiongenome-wideimplantationimprovedimproved outcomein vivoinsightmouse modelnatural Blastocyst Implantationnovelpre-clinicalpregnancy failurepregnantprognosticprogramspromoterreproductive outcomeresponsesuccesstranscription factortranscriptomeuterine receptivity
中文摘要
项目摘要
胚胎植入失败是世界范围内妇女不孕的重要原因。虽然进步
在我们对卵母细胞和胚胎发育的理解中,
部分由于子宫内膜不接受胚胎而保持不可接受的低水平。 为成功
着床、子宫内膜容受性和随后的蜕膜化需要协调的孕酮(P4)
以细胞类型特异性方式进行信号传导。 虽然支持P4-β驱动子宫的标志性细胞事件
接受性和蜕膜化是已知的,我们对P4作用的关键介质的知识,在这些
过程是不完整的。 这种知识的缺乏是重要的,因为没有什么短的识别关键早
支持P4-β受体驱动的子宫容受性的信号将解决目前诊断和治疗子宫内膜异位症的临床局限性。
在分子水平上治疗非受体子宫。 为了解决这个问题,我们最近证明了
早幼粒细胞白血病锌指(PLZF)转录因子是孕酮的直接靶点,
受体(PGR),是培养的人子宫内膜间质P4-β依赖性蜕膜化所必需的
细胞(hESC)。 作为PLZF在人子宫内膜中P4介导作用的进一步翻译支持,
人子宫内膜活检组织中PLZF表达水平在P4-β显性周期中显著诱导
人类非自然受孕月经周期的分泌期。 在早期妊娠小鼠中,
在接受子宫的上皮和间质区室中,在蜕膜细胞中强烈表达,
妊娠进展。 这些发现支持我们的假设,PLZF(及其下游转录
程序)作为P4-β依赖性子宫容受性和蜕膜化的关键介质,
子宫内膜细胞类型特异性。 这一假设将通过三个具体目标进行检验。 最近使用A
产生的携带Plzf条件等位基因的小鼠模型,特异性目的1将建立体内重要性
Plzf(及其转录程序)在P4-β依赖的子宫内膜容受性和蜕膜化中的作用。
在小鼠子宫内膜中的上皮和间质Plzf信号传导的个体贡献的剖析
围着床期将是具体目标2的主要焦点。 我们最近证明,
PLZF对早期生长反应1(EGR 1)转录因子的转录抑制是
hESC蜕膜化;阻断这种调节会损害hESC蜕膜化。 然而,在蜕膜化之前,
蜕膜前hESC中的EGR 1是这些细胞蜕膜化所必需的,这表明EGR 1“启动”了蜕膜前hESC。
蜕膜hESC用于蜕膜化。 具体目标3将通过分子表征
P4-β PGR-β PLZF-β EGR 1调节轴是体外和体内蜕膜化所必需的。 这些目标将
使用最先进的基因工程小鼠研究Plzf在子宫内膜容受性和蜕膜化中的作用,
以及高通量的基因组规模的方法来鉴定新的子宫内膜靶点,
Plzf和转录相互作用体,通过这种调节发生。
英文摘要
Project Summary
Embryo implantation failure is a significant causal factor of infertility for women worldwide. Although advances
in our understanding of oocyte and embryo development have improved pregnancy success rates, these rates
remain unacceptably low due in part to an endometrium that is nonreceptive to the embryo. For successful
implantation, endometrial receptivity and subsequent decidualization requires coordinated progesterone (P4)
signaling in a cell-type specific manner. While the signature cellular events that underpin P4-driven uterine
receptivity and decidualization are known, our knowledge of the pivotal mediators of P4 action in these
processes is incomplete. This knowledge-deficiency is significant as nothing short of identifying the key early
signals that underpin P4-driven uterine receptivity will address the current clinical limitations in diagnosing and
treating a non-receptive uterus at the molecular level. To address this deficiency, we recently demonstrated
that the promyelocytic leukemia zinc finger (PLZF) transcription factor is a direct target of the progesterone
receptor (PGR) and is indispensable for P4-dependent decidualization of cultured human endometrial stromal
cells (hESCs). As further translational support for a P4 mediator role for PLZF in the human endometrium,
PLZF expression levels in human endometrial biopsies are significantly induced during the P4-dominant
secretory phase of the human non-conception menstrual cycle. In the early pregnant mouse, Plzf is induced in
the epithelial and stromal compartments of the receptive uterus and is strongly expressed in decidual cells with
pregnancy progression. These findings support our hypothesis that PLZF (and its downstream transcriptional
program) acts as a pivotal mediator of P4-dependent uterine receptivity and decidualization and does so in an
endometrial cell-type specific manner. This hypothesis will be tested by three specific aims. Using a recently
generated mouse model carrying a Plzf conditional allele, Specific Aim 1 will establish the in vivo importance
of Plzf (and its transcriptional programs) in P4-dependent endometrial receptivity and decidualization.
Dissecting the individual contributions of epithelial and stromal Plzf signaling in the murine endometrium during
the periimplantation period will be a major focus of Specific Aim 2. We recently demonstrated that direct
transcriptional repression of the early growth response 1 (EGR1) transcription factor by PLZF is required for
hESC decidualization;; blocking this regulation impairs hESC decidualization. Prior to decidualization, however,
EGR1 in pre-decidual hESCs is required for these cells to decidualize, suggesting that EGR1 “primes” the pre-
decidual hESC for decidualization. Specific Aim 3 will address this proposal by molecularly characterizing the
P4-PGR-PLZF-EGR1 regulatory axis that is required for in vitro and in vivo decidualization. These aims will
use state-of-the-art engineered mice to study the role of Plzf in endometrial receptivity and decidualization as
well as high throughput genome-scale approaches to identify novel endometrial targets directly regulated by
Plzf and the transcriptional interactome through which this regulation occurs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Analysis of Uterine Receptivity
-
批准号:9300931
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2002
-
负责人:JOHN P LYDON
-
依托单位:
Molecular Analysis of Uterine Receptivity
-
批准号:9813937
-
项目类别:
-
资助金额:$34.0万
-
财政年份:2002
-
负责人:JOHN P LYDON
-
依托单位:
Molecular Analysis of Uterine Receptivity
-
批准号:8898860
-
项目类别:
-
资助金额:$32.07万
-
财政年份:2002
-
负责人:JOHN P LYDON
-
依托单位:
Molecular Analysis of Uterine Receptivity
-
批准号:10453621
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2002
-
负责人:JOHN P LYDON
-
依托单位:
Molecular Analysis of Uterine Receptivity
-
批准号:9105423
-
项目类别:
-
资助金额:$32.56万
-
财政年份:2002
-
负责人:JOHN P LYDON
-
依托单位:
Molecular Analysis of Uterine Receptivity
-
批准号:10663198
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2002
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR AND BREAST CANCER
-
批准号:6513371
-
项目类别:
-
资助金额:$10.97万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR IN BREAST DEVELOPMENT AND CANCER
-
批准号:6965687
-
项目类别:
-
资助金额:$31.88万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR AND BREAST CANCER
-
批准号:2597595
-
项目类别:
-
资助金额:$10.47万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR AND BREAST CANCER
-
批准号:6376709
-
项目类别:
-
资助金额:$11.06万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR AND BREAST CANCER
-
批准号:6173001
-
项目类别:
-
资助金额:$10.93万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR AND BREAST CANCER
-
批准号:6709736
-
项目类别:
-
资助金额:$1.52万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR IN BREAST DEVELOPMENT AND CANCER
-
批准号:7229070
-
项目类别:
-
资助金额:$30.22万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR IN BREAST DEVELOPMENT AND CANCER
-
批准号:7394451
-
项目类别:
-
资助金额:$30.22万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR IN BREAST DEVELOPMENT AND CANCER
-
批准号:7065681
-
项目类别:
-
资助金额:$31.13万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR AND BREAST CANCER
-
批准号:6896034
-
项目类别:
-
资助金额:$5.27万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR AND BREAST CANCER
-
批准号:2896440
-
项目类别:
-
资助金额:$10.81万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
海外基金